Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Andrean Simons"'
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Abstract Resistance to anti-cancer monoclonal antibody (mAb) therapy remains a clinical challenge. Previous work in our laboratory has shown that T cell help in the form of interleukin-2 maintains long-term NK cell viability and NK cell-mediated anti
Externí odkaz:
https://doaj.org/article/5a38ad7f8b4448029326cedc3eabfd19
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S1. Cal-27 tumor responses to anakinra differs by gender. (PPTX 113 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9f276f447cf4dacb52464787a9b6d6f
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S7. Nanoparticle delivery of IL-1a in combination with cetuximab does not significantly affect T cells levels in tumor. (PPTX 111 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f7b6815062b4fed6bd0ca0932eadcbb
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Table S1. Characteristics of R/M HNSCC patients treated with cetuximab-based therapy. (DOCX 19 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5437db79fd130940b614046d4a54236e
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S2. TUBO-EGFR tumor responses to cetuximab and IL-1 differs by gender. (PPTX 137 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34eda99047a9498d21f0ae552f2d4999
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S7. Nanoparticle delivery of IL-1a in combination with cetuximab does not significantly affect T cells levels in tumor. (PPTX 111 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::802ea3e13670b7ab2b787d876d6a9bb9
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Table S1. Characteristics of R/M HNSCC patients treated with cetuximab-based therapy. (DOCX 19 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86c059583ca3d7fa2c6f9950a616307e
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S5. Nanoparticle delivery of IL-1a in combination with cetuximab does not significantly affect NK cell levels in spleens. (PPTX 130 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f82e74a814db6dc093a4ce0e591d6cfb
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S3. Treatment with recombinant IL-1a triggers inflammation in the colonic mesentery. (PPTX 1628 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc20cb7a25d64acfd1160f574380c6fd
Autor:
Espinosa-Cotton, Madelyn, Rodman, Samuel, Ross, Kathleen, Jensen, Isaac, Sangodeyi-Miller, Kenley, McLaren, Ayana, Dahl, Rachel, Gibson-Corley, Katherine, Koch, Adam, Fu, Yang-Xin, Badovinac, Vladimir, Laux, Douglas, Balaji Narasimhan, Andrean Simons
Figure S2. TUBO-EGFR tumor responses to cetuximab and IL-1 differs by gender. (PPTX 137 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::233080722c408e818a5d4267377c823b